Collegium pharmaceutical, inc. (COLL)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Revenues
Product revenues, net

296,701

280,413

28,476

1,711

-

-

-

Cost of product revenues
Total cost of products revenues

193,660

165,677

2,595

213

-

-

-

Operating expenses
Research and development

10,340

8,661

8,572

14,948

7,975

14,959

14,157

Selling, general and administrative

116,449

126,760

92,756

80,632

18,932

2,706

1,885

Total costs and expenses

320,449

301,098

103,923

95,793

26,907

17,665

16,042

Income (loss) from operations

-23,748

-20,685

-75,447

-94,082

-26,907

-17,665

-16,042

Interest expense

909

20,130

-

94

-

252

-

Interest income

1,935

1,687

582

-

-439

-

-

Interest expense, net

-

-

-

-

-

-

-76

Gain on extinguishment of debt

-

-

-

-

91

-

-79

Change in fair value of derivative liability

-

-

-

-

-

-7

-79

Total other income (expense), net

-

-

-

-

-348

-252

-155

Net income (loss)

-22,722

-39,128

-74,865

-94,176

-27,255

-17,917

-16,197

Loss per share - basic and diluted

-0.68

-1.19

-2.47

-3.88

-1.48

-22.72

-4.06

Weighted-average shares - basic and diluted (in shares)

33,453

32,953

30,265

24,262

13,542

933

1,697